Acrospire Investment Management
Latest statistics and disclosures from Acrospire Investment Management's latest quarterly 13F-HR filing:
- Top 5 stock holdings are Syneron Medical Ltd ord, Patheon N V, POOSF, Tobira Therapeutics In, and represent 100.00% of Acrospire Investment Management's stock portfolio.
- Added to shares of these 1 stock: POOSF.
- Started 1 new stock position in POOSF.
- Reduced shares in these 10 stocks: PG, GIS, WMT, K, PEP, CPB, CCK, ATR, , .
- Sold out of its positions in AIR, ABBNY, ACCO, ACNB, ABM, AFL, AGCO, Ag Mtg Invt Tr, AGNC, AES.
- Acrospire Investment Management was a net seller of stock by $-107M.
- Acrospire Investment Management has $33k in assets under management (AUM), dropping by -99.97%.
- Central Index Key (CIK): 0001632612
Tip: Access up to 7 years of quarterly data
Positions held by Acrospire Investment Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Portfolio Holdings for Acrospire Investment Management
Acrospire Investment Management holds 4 positions in its portfolio as reported in the September 2017 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| Syneron Medical Ltd ord | 90.9 | $30k | 2.7k | 10.96 |
|
|
| Patheon N V | 9.1 | $3.0k | -50% | 100.00 | 30.00 |
|
| Poseidon Concepts Cor (POOSF) | 0.0 | $0 | NEW | 20k | 0.00 |
|
| Tobira Therapeutics In | 0.0 | $0 | 405.00 | 0.00 |
|
Past Filings by Acrospire Investment Management
SEC 13F filings are viewable for Acrospire Investment Management going back to 2016
- Acrospire Investment Management 2017 Q3 filed Oct. 26, 2017
- Acrospire Investment Management 2017 Q2 filed Aug. 11, 2017
- Acrospire Investment Management 2017 Q1 filed May 4, 2017
- Acrospire Investment Management 2016 Q4 filed Feb. 14, 2017
- Acrospire Investment Management 2016 Q3 filed Nov. 10, 2016
- Acrospire Investment Management 2016 Q2 filed Aug. 9, 2016
- Acrospire Investment Management 2016 Q1 filed May 10, 2016